Sijia Tao

Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques

Timothy N. Hoang, María Pino, Arun K. Boddapati et al. · Cell · 2020 · 211 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Cytotoxic triterpenoids from Ganoderma lucidum

Chun‐Ru Cheng, Qing‐Xi Yue, Zhiyuan Wu et al. · Phytochemistry · 2010 · 137 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Characterization of β- <scp>d</scp> - <i>N</i> ⁴ -Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus

Maryam Ehteshami, Sijia Tao, Keivan Zandi et al. · Antimicrobial Agents and Chemotherapy · 2017 · 99 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study

George Lau, Yves Benhamou, Guofeng Chen et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 94 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model

Woldeab B. Haile, Christina Gavegnano, Sijia Tao et al. · Neurobiology of Disease · 2016 · 84 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16